Clinical features and outcomes of nontransitional cell carcinomas of the urinary bladder: Analysis of 125 cases
Open Access
- 1 January 2015
- journal article
- research article
- Published by Medknow in Urology Annals
- Vol. 7 (2), 177-182
- https://doi.org/10.4103/0974-7796.150533
Abstract
Objectives: The aim was to evaluate pathologic diagnosis, treatment and prognosis of 125 patients with nontransitional cell carcinoma of the urinary bladder. Materials and Methods: A total of 3590 patients with bladder tumors operated in our clinic between September 1998 and May 2013 were retrospectively evaluated. A total of 125 patients (107 men and 18 women) with nontransitional cell bladder cancer, confirmed by histopathology, were included in this study. The patients' characteristics, including age, gender, smoking history, tumor size, and localization, histological types, pathological tumor stages, treatment modalities, and survival rates were all recorded. Results: Of these tumors, 47 (37.6%) were adenocarcinoma (AC), 42 (33.6%) were squamous cell carcinoma (SCC), 23 (18.4%) were undifferentiated carcinoma (UC), 13 (10.4%) were other types of bladder carcinoma. Sixty-three (50.4%) patients had undergone radical cystectomy and pelvic lymphadenectomy ± adjuvant treatment (chemotherapy [CT]/radiotherapy) and 52 (41.6%) patients received radiotherapy ± CT. The median survival time of patients with AC and SCC were significantly higher than patients with UC (AC vs UC, P = 0.001; SCC vs UC, P = 0.000; AC vs. SCC, P = 0.219). Median survival time was significantly higher in radical cystectomy ± adjuvant treatment group (P < 0.05) in all histological types. Conclusion: Prognosis of urinary bladder tumors was directly related to histological type and stage of the tumor. CT or radiotherapy has limited response rates. Early radical cystectomy should be performed to improve prognosis.Keywords
This publication has 23 references indexed in Scilit:
- Clinical outcome of primary small cell carcinoma of the urinary bladderOncoTargets and Therapy, 2013
- Cause–effect? Understanding the risk factors associated with bladder cancerExpert Review of Anticancer Therapy, 2012
- Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challengeDiagnostic Pathology, 2012
- Small Cell Carcinoma of the Urinary Bladder—Histogenesis, Genetics, Diagnosis, Biomarkers, Treatment, and PrognosisApplied Immunohistochemistry & Molecular Morphology, 2007
- Prospective Trial of Ifosfamide, Paclitaxel, and Cisplatin in Patients with Advanced Non-transitional Cell Carcinoma of the Urothelial TractUrology, 2007
- Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and managementInternational Journal of Clinical Oncology, 2005
- Tobacco, occupation and non-transitional-cell carcinoma of the bladder: An international case-control studyInternational Journal of Cancer, 1999
- Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic studyCancer, 1983
- Squamous Cell Carcinoma of Bladder. A Review of 114 PatientsBritish Journal of Urology, 1982
- Squamous Cell Carcinoma of the BladderJournal of Urology, 1976